Supplemental material
OncoImmunology
Volume 13, 2024 - Issue 1
Open access
1,727
Views
0
CrossRef citations to date
0
Altmetric
Original research
PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma
Mengjia Songa Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
https://orcid.org/0000-0002-6399-3412View further author information
Yue Huanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;d Department of Medical Oncology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaView further author information
, Ye Honga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Juan Liua Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China;e Department of Pediatric Oncology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaView further author information
, Jia Zhua Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Suying Lua Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Juan Wanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Feifei Suna Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Junting Huanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
, Jiaqian Xua Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China;e Department of Pediatric Oncology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaView further author information
, Yan Tanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;c Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
, View further author information
Jian-Chuan Xiaa Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;c Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-1268-3967View further author information
Yizhuo Zhanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2289738
|
Received 10 Aug 2023, Accepted 27 Nov 2023, Published online: 01 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.